Time & Date: 3 September, 17.45 – 18.45 CEST
Chairperson(s): A. Loewenstein ISRAEL
Speakers & Presentations:
A. Loewenstein Israel
Welcome and Introduction
F. Bandello ITALY
The Anti-VEGF Treatment Burden
M. Zinkernagel SWITZERLAND
Diagnostic Imaging & How to Track nAMD Disease Progression with Current Technology
A. Loewenstein ISRAEL
nAMD Treatment Protocols and Visual Outcome Goals
D. Pieramici USA
Current and Future Applications of Longer Lasting Anti-VEGF Therapeutics
All Faculty
Panel Discussion: Artificial Intelligence and At Home-monitoring in Treatment Decision-making
A. Loewenstein ISRAEL
Final Summary and Conclusion
